Gagandeep Singh, MD - Medicare Hospitalist in Hartford, CT

Gagandeep Singh, MD is a medicare enrolled "Hospitalist" physician in Hartford, Connecticut. He graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Hospitalist. He is a member of the group practice New England Md Health Partners Pllc, Trinity Health Of New England Provider Network Organization Inc and his current practice location is 114 Woodland St, Hartford, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 714-7446.

Gagandeep Singh is licensed to practice in Connecticut (license number 047332) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003055021.

Contact Information

Gagandeep Singh, MD
114 Woodland St,
Hartford, CT 06105-1208
(860) 714-7446
(860) 714-1508



Physician's Profile

Full NameGagandeep Singh
GenderMale
SpecialityHospitalist
Experience20 Years
Location114 Woodland St, Hartford, Connecticut
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Gagandeep Singh graduated from medical school in 2004
  NPI Data:
  • NPI Number: 1003055021
  • Provider Enumeration Date: 02/14/2009
  • Last Update Date: 11/11/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0941353007
  • Enrollment ID: I20090806000603

Medical Identifiers

Medical identifiers for Gagandeep Singh such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003055021NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 047332 (Connecticut)Secondary
208M00000XHospitalist 047332 (Connecticut)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Beacon Hospice LlcEast hartford, CTHospice
Masonicare Home Health And Hospice IncWallingford, CTHospice
Manchester Memorial HospitalManchester, CTHospital
St Francis Hospital & Medical CenterHartford, CTHospital
Johnson Memorial HospitalStafford springs, CTHospital
St Mary HomeWest hartford, CTNursing home
Meadowbrook Of GranbyGranby, CTNursing home
Touchpoints At ManchesterManchester, CTNursing home
Touchpoints At BloomfieldBloomfield, CTNursing home

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
New England Md Health Partners Pllc94365032576
Trinity Health Of New England Provider Network Organization Inc0941113567621

News Archive

New approach reduces JAK2 activity by pharmacologically targeting HSP90 protein

Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

Immunothrombotic dysregulation is key marker of disease severity in COVID-19

In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys. Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have now shown that activated immune cells and blood platelets play a major role in these pathologies.

No legal recourse because generic drug caused injury

Carrie Scott went in to the hospital for abnormal bleeding. Days later she returned home without her hand and forearm. The generic form of Phenergan was given improperly, apparently from an inadequate warning label. Scott has no legal recourse because a generic drug caused her injury, rather than its brand-name equivalent.

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Gagandeep Singh allows following entities to bill medicare on his behalf.
Entity NameTrinity Health Of New England Provider Network Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003882812
PECOS PAC ID: 0941113567
Enrollment ID: O20031110000651

News Archive

New approach reduces JAK2 activity by pharmacologically targeting HSP90 protein

Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

Immunothrombotic dysregulation is key marker of disease severity in COVID-19

In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys. Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have now shown that activated immune cells and blood platelets play a major role in these pathologies.

No legal recourse because generic drug caused injury

Carrie Scott went in to the hospital for abnormal bleeding. Days later she returned home without her hand and forearm. The generic form of Phenergan was given improperly, apparently from an inadequate warning label. Scott has no legal recourse because a generic drug caused her injury, rather than its brand-name equivalent.

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.

Read more Medical News

› Verified 1 days ago

Entity NameWecare Health Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346987864
PECOS PAC ID: 2961880422
Enrollment ID: O20220613000978

News Archive

New approach reduces JAK2 activity by pharmacologically targeting HSP90 protein

Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

Immunothrombotic dysregulation is key marker of disease severity in COVID-19

In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys. Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have now shown that activated immune cells and blood platelets play a major role in these pathologies.

No legal recourse because generic drug caused injury

Carrie Scott went in to the hospital for abnormal bleeding. Days later she returned home without her hand and forearm. The generic form of Phenergan was given improperly, apparently from an inadequate warning label. Scott has no legal recourse because a generic drug caused her injury, rather than its brand-name equivalent.

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.

Read more Medical News

› Verified 1 days ago

Entity NameNew England Md Health Partners Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700587987
PECOS PAC ID: 9436503257
Enrollment ID: O20230928000565

News Archive

New approach reduces JAK2 activity by pharmacologically targeting HSP90 protein

Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

Immunothrombotic dysregulation is key marker of disease severity in COVID-19

In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys. Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have now shown that activated immune cells and blood platelets play a major role in these pathologies.

No legal recourse because generic drug caused injury

Carrie Scott went in to the hospital for abnormal bleeding. Days later she returned home without her hand and forearm. The generic form of Phenergan was given improperly, apparently from an inadequate warning label. Scott has no legal recourse because a generic drug caused her injury, rather than its brand-name equivalent.

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gagandeep Singh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Gagandeep Singh, MD
1000 Asylum Ave, Suite 2109a,
Hartford, CT 06105-1770

Ph: (860) 714-6581
Gagandeep Singh, MD
114 Woodland St,
Hartford, CT 06105-1208

Ph: (860) 714-7446

News Archive

New approach reduces JAK2 activity by pharmacologically targeting HSP90 protein

Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

Immunothrombotic dysregulation is key marker of disease severity in COVID-19

In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys. Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have now shown that activated immune cells and blood platelets play a major role in these pathologies.

No legal recourse because generic drug caused injury

Carrie Scott went in to the hospital for abnormal bleeding. Days later she returned home without her hand and forearm. The generic form of Phenergan was given improperly, apparently from an inadequate warning label. Scott has no legal recourse because a generic drug caused her injury, rather than its brand-name equivalent.

Nuvo Research's PENNSAID now available in U.S. pharmacies

Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.

Read more News

› Verified 1 days ago


Hospitalist Doctors in Hartford, CT

Dr. Anuradha Kapur, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Dept. Of Medicine, Hartford, CT 06105
Phone: 860-714-7446    Fax: 860-714-1508
Fakhar J Khan, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 80 Seymour Street, Hartford Hospital Cariology Dept, Hartford, CT 06102
Phone: 860-972-4398    
Gagan D. Singh, M.D
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Department Of Medicine, Hartford, CT 06105
Phone: 860-714-7446    Fax: 860-714-1508
Dr. Danilo Manalese Pangilinan, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 21 Woodland St, Hartford, CT 06105
Phone: 860-527-6745    Fax: 860-293-2021
Dr. John Joseph Osowski, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Dept Of Medicine, Hartford, CT 06105
Phone: 860-714-7446    
Theodore R Hartenstein, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Dept. Of Medicine, Hartford, CT 06105
Phone: 860-714-7446    Fax: 860-714-1508
Hemal Patel, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Department Of Medicine, Hartford, CT 06105
Phone: 860-714-7446    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.